Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunocore Holdings (IMCR)
NASDAQ:IMCR
Immunocore Holdings (IMCR) Stock Price & Analysis
98 Followers
IMCR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$42.21 - $67.43
Previous Close$52.58
Volume283.05K
Average Volume (3M)301.86K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)£332.54M
Total Debt (Recent Filing)£69.30M
Price to Earnings (P/E)-18.5
Beta0.76
Next Earnings
Feb 29, 2024EPS Estimate
-$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.85
Shares Outstanding48,088,346
10 Day Avg. Volume374,642
30 Day Avg. Volume301,863
Standard Deviation0.15
R-Squared0.09
Alpha0.00775
Financial Highlights & Ratios
Price to Book (P/B)8.07
Price to Sales (P/S)17.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio404.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$80.25Price Target Upside51.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Immunocore Holdings News
Stock Analysis & Ideas3 Best Stocks to Buy Now, 11/21/2023, According to Top Analysts
Ownership Overview
0.00% Insiders
14.33% Mutual Funds
44.57% Other Institutional Investors
41.10% Public Companies and
Individual Investors
IMCR FAQ
What was Immunocore Holdings’s price range in the past 12 months?
Immunocore Holdings lowest stock price was $42.21 and its highest was $67.43 in the past 12 months.
What is Immunocore Holdings’s market cap?
Currently, no data Available
When is Immunocore Holdings’s upcoming earnings report date?
Immunocore Holdings’s upcoming earnings report date is Feb 29, 2024 which is in 84 days.
How were Immunocore Holdings’s earnings last quarter?
Immunocore Holdings released its earnings results on Nov 07, 2023. The company reported $0.051 earnings per share for the quarter, beating the consensus estimate of -$0.363 by $0.414.
Is Immunocore Holdings overvalued?
According to Wall Street analysts Immunocore Holdings’s price is currently Undervalued.
Does Immunocore Holdings pay dividends?
Immunocore Holdings does not currently pay dividends.
What is Immunocore Holdings’s EPS estimate?
Immunocore Holdings’s EPS estimate is -$0.26.
How many shares outstanding does Immunocore Holdings have?
Immunocore Holdings has 48,088,345 shares outstanding.
What happened to Immunocore Holdings’s price movement after its last earnings report?
Immunocore Holdings reported an EPS of $0.051 in its last earnings report, beating expectations of -$0.363. Following the earnings report the stock price went up 5.712%.
Which hedge fund is a major shareholder of Immunocore Holdings?
Among the largest hedge funds holding Immunocore Holdings’s share is Baker Bros Advisors LP. It holds Immunocore Holdings’s shares valued at 131M.
---
Immunocore Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$80.25 (51.04% Upside)
$80.25 (51.04% Upside)
Blogger Sentiment
Bullish
IMCR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 7.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.4%
Last 30 Days ▲ 17.9%
Last 30 Days ▲ 17.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.45%
12-Months-Change
Fundamentals
Return on Equity
-19.00%
Trailing 12-Months
Asset Growth
14.12%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Immunocore Holdings
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases.
---
Top 5 ETFs holding IMCR
Fidelity Nasdaq Composite Index ETF
$286.74K
Up to five ETFs with an Outperform Smart Score that hold IMCR. The ETFs are listed according to market value of IMCR within the ETF
Apellis Pharmaceuticals
―
Adaptimmune Therapeutics
―
Kura Oncology
―
Crispr Therapeutics AG
―
---